These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7909438)

  • 61. Antisense gene inhibition by phosphorothioate antisense oligonucleotide in Arabidopsis pollen tubes.
    Mizuta Y; Higashiyama T
    Plant J; 2014 May; 78(3):516-26. PubMed ID: 24495108
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay.
    Vaughn JP; Iglehart JD; Demirdji S; Davis P; Babiss LE; Caruthers MH; Marks JR
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8338-42. PubMed ID: 7667291
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotides.
    Stewart AJ; Canitrot Y; Baracchini E; Dean NM; Deeley RG; Cole SP
    Biochem Pharmacol; 1996 Feb; 51(4):461-9. PubMed ID: 8619891
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antisense oligonucleotides directed against p53 have antiproliferative effects unrelated to effects on p53 expression.
    Barton CM; Lemoine NR
    Br J Cancer; 1995 Mar; 71(3):429-37. PubMed ID: 7880719
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reversal of multiple drug resistance in vitro by phosphorothioate oligonucleotides and ribozymes.
    Bertram J; Palfner K; Killian M; Brysch W; Schlingensiepen KH; Hiddemann W; Kneba M
    Anticancer Drugs; 1995 Feb; 6(1):124-34. PubMed ID: 7756675
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Psoralen-modified clamp-forming antisense oligonucleotides reduce cellular c-Myc protein expression and B16-F0 proliferation.
    Stewart DA; Thomas SD; Mayfield CA; Miller DM
    Nucleic Acids Res; 2001 Oct; 29(19):4052-61. PubMed ID: 11574688
    [TBL] [Abstract][Full Text] [Related]  

  • 67. c-erbB-2 anti-sense phosphorothioate oligodeoxynucleotides inhibit growth and serum-induced cell spreading of P185c-erbB-2-overexpressing ovarian carcinoma cells.
    Wiechen K; Dietel M
    Int J Cancer; 1995 Nov; 63(4):604-8. PubMed ID: 7591273
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase.
    Monia BP; Johnston JF; Geiger T; Muller M; Fabbro D
    Nat Med; 1996 Jun; 2(6):668-75. PubMed ID: 8640558
    [TBL] [Abstract][Full Text] [Related]  

  • 69. erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.
    Colomer R; Lupu R; Bacus SS; Gelmann EP
    Br J Cancer; 1994 Nov; 70(5):819-25. PubMed ID: 7947086
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of the erbB-2 tyrosine kinase receptor in breast cancer cells by phosphoromonothioate and phosphorodithioate antisense oligonucleotides.
    Vaughn JP; Stekler J; Demirdji S; Mills JK; Caruthers MH; Iglehart JD; Marks JR
    Nucleic Acids Res; 1996 Nov; 24(22):4558-64. PubMed ID: 8948649
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulin-like growth factor I receptor in ovarian cancer cells.
    Müller M; Dietel M; Turzynski A; Wiechen K
    Int J Cancer; 1998 Aug; 77(4):567-71. PubMed ID: 9679760
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The reduction of Raf-1 protein by phosphorothioate ODNs and siRNAs targeted to the same two mRNA sequences.
    Lou TF; Gray CW; Gray DM
    Oligonucleotides; 2003; 13(5):313-24. PubMed ID: 15000822
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Regulation of p56lck kinase expression and control of DNA synthesis in activated human B lymphocytes.
    Taieb J; Vitte-Mony I; Auffredou MT; Dorseuil O; Gacon G; Bertoglio J; Vazquez A
    J Biol Chem; 1993 May; 268(13):9169-71. PubMed ID: 7683644
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acridine-modified, clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-Myc expression and B16-F0 tumor progression.
    Stewart DA; Xu X; Thomas SD; Miller DM
    Nucleic Acids Res; 2002 Jun; 30(11):2565-74. PubMed ID: 12034846
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Specific detection of c-erbB-2 mRNA expression in gastric cancers by the polymerase chain reaction following reverse transcription.
    Ninomiya I; Endo Y; Yonemura Y; Noguchi M; Fushida S; Nakai M; Takamura H; Harada F; Suzuki T; Miyazaki I
    Br J Cancer; 1992 Jul; 66(1):84-7. PubMed ID: 1379062
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Specific inhibition of transforming growth factor-beta2 expression in human osteoblast cells by antisense phosphorothioate oligonucleotides.
    Shen ZJ; Kim SK; Kwon OS; Lee YS; Moon BJ
    Eur J Biochem; 2001 Apr; 268(8):2331-7. PubMed ID: 11298751
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Oligonucleotides conjugated to natural lipids: synthesis of phosphatidyl-anchored antisense oligonucleotides.
    Chillemi R; Greco V; Nicoletti VG; Sciuto S
    Bioconjug Chem; 2013 Apr; 24(4):648-57. PubMed ID: 23451795
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides.
    Hélène C
    Eur J Cancer; 1991; 27(11):1466-71. PubMed ID: 1835863
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Topical and intravitreous administration of cationic nanoemulsions to deliver antisense oligonucleotides directed towards VEGF KDR receptors to the eye.
    Hagigit T; Abdulrazik M; Orucov F; Valamanesh F; Hagedorn M; Lambert G; Behar-Cohen F; Benita S
    J Control Release; 2010 Aug; 145(3):297-305. PubMed ID: 20420865
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hairpin extensions enhance the efficacy of mycolyl transferase-specific antisense oligonucleotides targeting Mycobacterium tuberculosis.
    Harth G; Zamecnik PC; Tabatadze D; Pierson K; Horwitz MA
    Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7199-204. PubMed ID: 17438292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.